AnGes MG Inc. | Mutual Funds
Mutual Funds that own AnGes MG Inc.
Monega Innovation
50,000
0.06%
0
0.38%
07/31/2018
SPDR S&P International Small Cap ETF
49,800
0.06%
0
0.03%
09/06/2018
DIAM (Japan) Domestic Equity Open
30,000
0.03%
30,000
0.07%
08/29/2017
GO UCITS ETF Solutions Plc - Longer Dated All Commodities
11,000
0.01%
11,000
0.01%
02/28/2018
Bayview Asset Japanese Equity Long Short Mother Fund
5,999
0.01%
5,999
0.34%
11/27/2017
New Zealand Superannuation Fund
0
0%
-4,400
0%
06/30/2017
Government Pension Fund - Global (The)
0
0%
-379,778
0%
12/31/2017
| Address |
Saito Bio-Incubator 1F
Osaka Osaka 567
Japan
|
|
Employees
|
- |
| Website |
http://www.anges.co.jp |
| Updated |
07/08/2019 |
| AnGes, Inc. engages in the research and development of gene-based medical products. It offers genetic medicines such as hepatocyte growth factor (HGF) genetic medicines, NF-KB decoy oligo and hemagglutinating virus of Japan envelope (HVJ-E) non-viral vector, and others. It is also involved in the research and development of medical equipment, which improves blood circulation by regenerating blood vessels and NfkB which controls various inflammations. |
